S.4348: FDASLA Act of 2022

About This Bill

Bill Versions

Bill Summary

Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 This bill modifies Food and Drug Administration (FDA) authority to collect certain fees. It also expands FDA authority to regulate certain products, including cosmetics. Among other provisions, the bill reauthorizes FDA authority to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such...

(Source: Library of Congress)

Bill Actions

Date Description
July 13, 2022
Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.
July 13, 2022
Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.
June 14, 2022
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
May 26, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 26, 2022

Introduced in the Senate by Patty Murray (D-Wash.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page